Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years

Journal of Medical Virology
Berta PernasEva Poveda

Abstract

To describe temporal trend and characteristics of newly HIV-diagnosed patients in a medical care area in Northwest Spain over the last 10 years. All newly diagnosed patients for HIV-infection from 2004 to 2013 at a reference medical care area in Northwest of Spain were identified. Epidemiological, virological, immunological, and clinical data, as well as HIV genotype and drug resistance information were recorded. A total of 565 newly HIV-diagnosed patients were identified. The number of new cases increased in the last 5 years (66 cases/year). Overall, 53.1% had a median CD4 counts < 350 cells/µl and 33.6% had an AIDS defining criteria. Non-B variants were found in 34.4% of patients being subtype F (25.8%) the most common non-B subtype. The rate of transmitted drug resistance (TDR) over the study period was 3.7%, but a decreased to 2.6% was observed in the last 5 years. The most prevalent TDR mutations were: T215 revertants (1.5%), K219QENR (1.2%), for NRTIs; K103N (1.9%), for NNRTIs; L90M (0.3%), for PIs. Overall, 73.2% of patients started antiretroviral treatment and 9.9% of patients died during follow-up. The number of newly HIV diagnosed patients increased since year 2009. There is a high prevalence of late diagnosis (53%) a...Continue Reading

References

Jul 14, 1998·AIDS·C ApetreiF Simon
Apr 17, 2001·AIDS Care
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul E SaxKenneth A Freedberg
Aug 11, 2007·AIDS·Andrew N PhillipsUNKNOWN UK Collaborative HIV Cohort Study
Aug 24, 2007·The Journal of Antimicrobial Chemotherapy·Abdurrahman SagirUNKNOWN RESINA Study Team
Oct 10, 2007·Epidemiology and Infection·D L YirrellD Goldberg
Mar 25, 2008·Enfermedades infecciosas y microbiología clínica·Rosario PalaciosUNKNOWN Grupo Malagueño para el Estudio de las Enfermedades Infecciosas
Jan 20, 2009·Journal of Medical Virology·Joana Paixão MonteiroBernardo Galvão-Castro
Jun 18, 2009·Current Opinion in HIV and AIDS·Frits van GriensvenAndrew Grulich
Sep 10, 2009·Revista Do Instituto De Medicina Tropical De São Paulo·Cláudia Fontoura DiasLuis Fernando Brigido
Oct 22, 2009·AIDS Research and Human Retroviruses·Carmen De MendozaVincent Soriano
May 14, 2010·Antiviral Therapy·Santiago MorenoAntonella d'Arminio Monforte
Feb 8, 2011·AIDS·Joris HemelaarUNKNOWN WHO-UNAIDS Network for HIV Isolation and Characterisation
Jul 20, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·LeeAnne M LuftDeirdre L Church
Oct 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexandra U ScherrerUNKNOWN Swiss HIV Cohort Study
Feb 14, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael M ThomsonLucía Pérez-Álvarez
Sep 29, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S MongeUNKNOWN CoRIS
Dec 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marie-Laure ChaixUNKNOWN ANRS PRIMO Cohort Study Group
Mar 30, 2013·BMC Public Health·Laura CamoniUNKNOWN regional representatives of the HIV Surveillance System
May 24, 2013·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force*
Sep 13, 2013·BMC Infectious Diseases·Yinzhong ShenJiangrong Wang
Sep 27, 2013·HIV Medicine·P Fernández-DávilaJ Casabona
Oct 8, 2013·Journal of the International AIDS Society·Nahuel Rodriguez-RodriguesDario A Dilernia
Oct 12, 2013·BMC Infectious Diseases·Paola ScognamiglioUNKNOWN SENDIH Study Group

❮ Previous
Next ❯

Citations

Dec 22, 2016·PloS One·Santiago Pérez-ParraFederico García
Feb 26, 2019·Journal of the International Association of Providers of AIDS Care·Purificación Cid-SilvaEva Poveda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.